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Abstract
Background Positive psychological characteristics in 
people with type 2 diabetes (T2D) are associated with 
better health and longevity, and one plausible physiolog-
ical mechanism involves lower markers of inflammation. 
Positive affect is related to lower basal inflammatory 
markers and smaller inflammatory responses to acute 
stress, but this association in people with T2D remains 
to be examined.
Purpose To examine the relationship between happiness 
and inflammatory markers at baseline and in response to 
acute stress in people with T2D.
Methods One hundred forty people with T2D took 
part in laboratory-based stress testing. We aggregated 
daily happiness ratings over 7  days before stress test-
ing. During the laboratory session, participants under-
went two mental stress tasks—the mirror tracing and 
the Stroop task. Blood was sampled at baseline and 
post-stress (up to 75  min post-stress) to detect plasma 
interleukin-6 (IL-6), interleukin-1 receptor antagon-
ist (IL-1Ra), and monocyte chemoattractant protein-1 
(MCP-1). Associations between happiness and inflam-
matory markers and responses were analyzed using mul-
tivariable linear regressions.
Results Greater daily happiness significantly predicted 
lower baseline and post-stress IL-6 concentrations, and 
lower baseline MCP-1, after adjusting for covariates. The 
association between happiness and reduced basal IL-6 
maintained after further controlling for daily sadness. 
We did not find significant associations between daily 
happiness and inflammatory responses to acute stress. 
No associations were detected for IL-1Ra.
Conclusions Happier individuals with T2D have lower 
inflammatory markers before and after acute stress, 
albeit independent of stress responsivity. Findings could 
provide a protective physiological pathway linking daily 
happiness with better health in people with T2D.
Keywords  Type 2 diabetes • Happiness • Mental stress • 
Inflammatory markers • Stress responses
Positive affect encompasses feelings that reflect a state 
of  pleasurable engagement with the environment such 
as happiness, excitement, joy, and contentment [1], 
and is a component of  the broader theoretical concept 
of  subjective well-being [2]. Accumulating evidence 
acknowledges the protective role of  positive affect on 
physical health, revealing that people who experience 
more positive affect live healthier and longer lives [3, 
4]. The impact of  positive psychological characteristics 
including positive affect, life enjoyment, self-efficacy, 
and resilience in people with type 2 diabetes (T2D) has 
also been documented, delineating significant asso-
ciations with better glycemic control, fewer diabetes 
complications, and lower risk of  cardiac morbidity and 
mortality [5–7]. The pathways linking positive affect 
with better health in T2D are unclear, but one plausible 
mechanism involves lower markers of  inflammation [8].
Increased concentration of inflammatory markers 
reflects activation of the innate immune system following 
acute stress [9]. Inflammatory markers include a range of 
cytokines, including interleukin (IL)-6, IL-1, and mono-
cyte chemoattractant protein (MCP)-1. IL-6 is produced 
by a variety of cell types after stimulation by the pro-in-
flammatory cytokine IL-1b, and in turn stimulates the 
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synthesis of the acute phase C-reactive protein (CRP) 
by hepatocytes [9]. The anti-inflammatory agent, IL-1 
receptor antagonist (IL-1Ra) inhibits IL-1 action [10], 
and IL-1 and IL-6 administration can induce IL-1Ra 
secretion [11–13]. MCP-1 is included in the chemo-
attractant cytokines family. It is produced after stimula-
tion by other cytokines and is involved in the regulation 
of migration and infiltration of macrophages [14].
Both basal/resting levels of inflammatory markers 
and inflammatory responses/changes in levels after acute 
stress are of importance, as they can be indicative of 
either high circulating concentrations or dysregulated 
responses to naturalistic stressors [15]. Laboratory stress 
testing is a widely used research strategy that can pro-
vide insights into inflammatory responses by measur-
ing inflammatory markers before and after acute stress 
task. A standard stress protocol is used and measures are 
taken under controlled conditions, reducing the impact 
of confounders. The focus of this strategy is on changes 
in markers from baseline to post-task and up to recov-
ery, which could not be detectable if  single measures 
were taken [16, 17]. IL-6, IL-1Ra, and MCP-1 have been 
found to increase after mental stress tasks in the labora-
tory [9, 18, 19], although responses are more consistent 
for IL-6 than the other measures [9, 18].
Heightened circulating inflammatory markers and 
dysregulated responses to acute stress are both clinically 
significant, and relevant to diabetes development and 
prognosis. Meta-analytic results showed that increased 
circulating IL-6 levels in initially healthy participants 
predict T2D onset [20]. People with established T2D 
have higher baseline and post-stress IL-6 levels com-
pared with healthy sample [21, 22]. Increased basal levels 
in IL-6, IL-1Ra, or MCP-1 are associated with coronary 
heart disease (CHD [23–26]), which is a macrovascular 
complication of diabetes [27]. Notably, increased IL-6 in 
people with T2D has been prospectively associated with 
macrovascular events and mortality [28]. Larger IL-6 
responses to laboratory stress have also been associated 
with cardiovascular risk factors in a 3-year follow-up 
study [29].
Positive affect could act protectively upon health and 
longevity in people with T2D through lower inflam-
matory markers and/or smaller inflammatory stress 
responses. In a large study of  2,873 healthy volunteers, 
positive affect, as assessed by aggregating ecological 
momentary assessments (EMA) repeatedly over the 
day, was inversely associated with IL-6 concentrations 
in women [30]. Moreover, a U.S. nationally represent-
ative study involving 969 participants demonstrated a 
significant relationship between daily positive events 
over eight consecutive days and reduced basal IL-6 [31]. 
Similarly, greater decreases in positive affect on stressful 
days were predictive of  elevated IL-6 [32]. Trait positive 
affect has also been linked to lower stimulated IL-6 
levels in a healthy, community sample [33], and lower 
IL-6 in chronic heart failure patients [34]. Associations 
between IL-6 and other positive constructs such as pur-
pose in life, positive relationships, and optimism have 
also been reported [35, 36]. Interestingly, the associ-
ation between positive affect and reduced IL-6 was 
maintained after adjustment for depressive symptoms 
in some studies [30, 34], suggesting that this relation-
ship is not secondary to the absence of  negative affect. 
Less research investigated the association between 
IL-1Ra and MCP-1 and psychosocial factors. However, 
elevated MCP-1 has been linked with depressive symp-
toms [37, 38] and chronic psychosocial stress [39], 
whereas both MCP-1 and IL-1Ra have been associated 
with loneliness in women [19].
Positive psychological attributes have also been linked 
to smaller inflammatory stress responses. In particular, 
we previously showed that stress responses in fibrinogen, 
which is another marker of inflammation, were attenu-
ated immediately after task in people reporting greater 
daily happiness using EMA [40]. Similarly, optimism 
has been associated with smaller IL-6 responses 2  hr 
post-task [41]. A more recent study showed that greater 
increases in negative mood after experimentally induced 
sedentariness predicted greater IL-6 responses at 45 min 
post-task [42]. Loneliness has also been associated with 
larger IL-1Ra increases immediately and up to 45  min 
post-task in middle-aged women [19].
Considering the lack of  research linking positive 
affect and inflammatory responses in people with T2D, 
the purpose of  this study was to examine the relation-
ship between positive affect and IL-6, IL-1Ra, and 
MCP-1 at resting and in response to acute stress in peo-
ple with T2D. In the current study, we assessed hap-
piness as a measure of  positive affect. Specifically, we 
deliberately recorded happiness ratings once-a-day over 
seven consecutive days to provide an aggregated meas-
ure of  daily mean happiness as our predictor variable. 
Previous research indicated that this method shows 
wider associations with biological stress responses 
than a retrospective assessment of  positive affect over 
the previous week using a standard mood scale [43]. 
Aggregated daily measures may provide a more reli-
able estimate of  affect that is not biased by transient 
moods on a single day, or recall bias, as well as involve 
a smaller burden for participants compared with EMA-
derived measures [40].
Concluding, we hypothesized that happier partici-
pants would have lower inflammatory markers at base-
line and after stress, and smaller inflammatory stress 
responses. Our secondary hypothesis was that the rela-
tionship between daily happiness and inflammatory 
markers/responses was independent of daily sadness.
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Method
Participants
A total of 140 people aged 50 to 75  years with doc-
tor-verified T2D diagnosis participated in laborato-
ry-based experimental stress testing. Participants were 
recruited from diabetic outpatient and primary care 
clinics in London between March 2011 and July 2012. 
People who reported history or previous diagnosis of 
CHD, inflammatory diseases, allergies, or mood disor-
ders were excluded from the study. Obesity is one of the 
main risk factors for diabetes [44]; therefore, it was not 
possible to exclude individuals with obesity from this 
study. To detect small to moderate effect sizes (δ = 0.32, 
p  <  .05), we aimed to recruit at least 125 participants. 
A  fully informed written consent was obtained by all 
participants, and ethical approval was granted by the 
UK National Research Ethics Service.
All participants were requested to avoid taking 
anti-inflammatory or antihistamine medication up to 
7 days before laboratory session. Participants were also 
instructed to avoid vigorous exercise and drinking alco-
hol from the evening before the session and caffeine or 
smoking for at least 2  hr before stress testing. On the 
day of testing, participants who reported colds or other 
infections were rescheduled.
Procedure
Daily diaries were collected for 7 days before the labo-
ratory session for the measurement of daily happiness. 
Participants were then tested individually in our light 
and temperature controlled laboratory, either in the 
morning or in the afternoon. We first measured height 
and weight for the body mass index (BMI) calculation. 
A venous cannula was then inserted and the participant 
rested for 30 min. During the last 5 min of the resting 
phase a blood sample was drawn for the measurement 
of baseline inflammatory markers. We then administered 
two mental stress tasks for 5 min each. Blood samples 
were obtained again immediately after the tasks and 45 
and 75  minutes later. Other factors measured but not 
reported in this paper included blood pressure, heart 
rate, and salivary cortisol [22].
Measures
Predictor variable: Daily mean happiness
We measured daily happiness using ratings made at the 
end of each day (every evening) for seven consecutive 
days before the laboratory testing. Participants were 
asked to report the extent to which they had been feeling 
happy on that day using a five-point Likert scale from 0 
(not at all) to 4 (a lot). We computed an average happi-
ness score over the week as our predictor variable. This 
method was introduced by Cohen and colleagues [45], 
and has been used in more recent studies [43]. Mean 
coefficient of variation over the week was 0.28, suggest-
ing a relatively small variability in data on average.
Outcome variables: IL-6, IL-1Ra, and MCP-1
Blood samples were drawn at four time points (baseline, 
immediately post-task, 45  min post-task, and 75  min 
post-task) for the measurement of plasma IL-6, IL-1Ra, 
and MCP-1. Samples were immediately centrifuged at 
2,500 rpm for 10 min at room temperature using ethylene-
diaminetetraacetic acid tubes. Plasma was removed from 
the tube and aliquoted into 0.5 ml portions and stored at 
−80° Celsius until batch analysis at a later date. Plasma 
IL-6 was analyzed with Quantikine high sensitivity two-
site enzyme-linked immunosorbent assay (ELISA) from 
R&D Systems (Oxford, UK). The minimum limit of 
detection was between 0.016 and 0.110 pg/ml. IL-1Ra 
and MCP-1 were analyzed in duplicate using fluores-
cent-labeled capture antibody beads from Millipore 
(Milliplex Human Cytokine/Chemokine kit, Millipore 
Corporation, US), and concentrations were measured 
using Luminex flow cytometer technology from Bio Rad 
(Bio-Plex, Hercules, CA, USA). The limit of detection 
for IL-1Ra was 2.3 pg/ml and for MCP-1 was 1.2 pg/ml. 
The mean intra-assay coefficients of variation for IL-6, 
IL-1Ra, and MCP-1 were 7.3%, 4.6%, and 6.1%, respec-
tively. Then mean inter-assay coefficients of variation for 
the three markers were 7.7%, 6%, and 12% respectively.
Covariates
Covariates were selected a priori as previous research 
indicates that these factors can influence inflammatory 
activity: age [46], sex [46–48], BMI (kg/m2 [49]), smoking 
(smoker/non-smoker [18]), and household income as an 
indicator of socioeconomic status (<£20,000, £20,000–
40,000, £40,000–60,000, >£60,000 [50]). Age, sex, smok-
ing status, and household income were recorded by 
self-report. BMI was calculated after measuring height 
and weight using standardized techniques on the day of 
testing. Health status is known to influence inflamma-
tory stress responses [9], therefore diabetic medication at 
the time of testing was selected (oral antidiabetic drugs/
insulin or other injectable diabetic medication). Diabetic 
medication was recorded by self-report and confirmed by 
inspection of medication packaging on the day of test-
ing. IL-6 shows marked diurnal variation with increasing 
levels over the course of the day [51]; therefore, time of 
testing (am or pm) was also selected. In preliminary ana-
lysis, we found that happiness showed marginally signif-
icant differences between the three marital status groups 
(single, married, and divorced or separated or widowed 
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as recorded by self-report), and therefore marital status 
was also included as a covariate. To control for the effects 
of daily sadness, an average sadness score was recorded 
by aggregating ratings made at the end of each day for 
7 days before laboratory session (same as with daily hap-
piness measurement). Participants were asked to report 
the extent to which they had been feeling sad on that day 
using a five-point Likert scale from 0 (not at all) to 4 
(a lot). Mean coefficient of variation over the week was 
1.18.
Other measures
Ethnicity (White, Asian, Afro-Caribbean, and Other), 
educational level (no qualification/elementary school 
diploma, up to O levels/middle or junior high school 
diploma, A-levels-ONC/high school or senior high 
school diploma, degree/university undergraduate cer-
tificate or above), and hours of moderate/vigorous 
physical activity per week were recorded by self-report. 
Cardiovascular medication at the time of testing was 
also recorded by self-report and confirmed by inspec-
tion of medication packaging on the day of testing. It 
was subsequently categorized into anti-hypertensive 
medication, beta-blockers, cholesterol-lowering drugs, 
and aspirin. In preliminary analysis, anti-hypertensive 
medication or beta-blockers use were not significantly 
associated with baseline inflammatory markers or stress 
responses, therefore these factors were not included as 
covariates. Glycated hemoglobin (HbA1c) was assessed 
from the baseline blood draw using standardized tech-
niques. Subjective stress was measured at baseline, imme-
diately post-task, and 45 and 75 min post-task. We asked 
participants “how stressed do you feel at the moment” 
(baseline), “how stressed did you feel during the task” 
(immediately post-task), and “how stressed do you feel 
at the moment” (45 and 75  min post-task). Responses 
were recorded on a seven-point scale, with higher scores 
indicating greater subjective stress.
Mental Stress Tasks
Two 5-min standardized mental tasks were administered 
in random order to induce stress responses, namely an 
electronic version of the Stroop color-word interference 
task and the mirror tracing task. These challenges are 
widely used in experimental studies and have been used in 
numerous previous investigations by our research group 
[52, 53]. Briefly, the color-word interference task required 
successive reporting of target color words (e.g., blue and 
red) printed in an incongruous color. The mirror trac-
ing task required participants to move a mental stylus to 
trace a star while looking at the mirror image. When the 
stylus comes off  the star, a mistake is counted by a loud 
noise emitted by the device (Lafayette Instruments Corp, 
Lafayette, IN). Participants were informed that the aver-
age person can achieve five tracings in the time given.
Statistical Analysis
We used mean happiness score over a 7-day period as 
our independent variable and three inflammatory mark-
ers (IL-6, IL-1Ra, and MCP-1) as our dependent varia-
bles. MCP-1 values were normally distributed, but IL-6 
and IL-1Ra were skewed thus were log-n transformed 
before main analysis. We checked univariate associ-
ations between happiness and sample characteristics 
using Pearson’s r correlations for continuous variables, 
and t-tests and one-way between-subjects Analysis 
of Variance (ANOVA) for categorical variables. We 
also checked associations between baseline inflamma-
tory markers and their patterns of responsivity using 
Pearson’s r correlations. To test for the effects of stress 
trial on subjective stress and inflammatory levels, sub-
jective stress ratings, and inflammatory markers were 
examined across four time points: baseline, immediately 
post-task, 45 min, and 75 min post-task using one-way 
repeated-measures ANOVA.
The association between happiness and inflamma-
tory markers was analyzed using multivariable linear 
regressions on baseline IL-6, IL-1Ra, and MCP-1 values 
as well as regressions on the post-task values (immedi-
ately post-task, 45 min post-task, and 75 min post-task) 
with all analyses adjusted for age, sex, BMI, smoking, 
household income, marital status, oral antidiabetic med-
ication, insulin/other injectable diabetic medication, and 
time of testing. Significant results were further adjusted 
for daily mean sadness. Separate regression analysis was 
conducted for each inflammatory marker and at each 
time point.
The association between happiness and inflamma-
tory stress responses was analyzed using multivaria-
ble linear regressions on the mean changes between 
baseline and post-task values; immediately post-task 
minus baseline, 45  min post-task minus baseline, and 
75 min post-task minus baseline, with analyses adjusted 
for age, sex, BMI, smoking, household income, mari-
tal status, oral antidiabetic medication, insulin/other 
injectable diabetic medication, and time of  testing. 
Separate regression analysis was run for each inflam-
matory marker and at each time point. Data from the 
regression analyses are reported as unstandardized B 
coefficients.
Sensitivity analysis was carried out to check for sig-
nificant differences in the characteristics of participants 
between those with full data on inflammatory markers 
and those with missing data on at least one inflamma-
tory marker. Statistical analyses were conducted using 
SPSS version 24 (SPSS, Chicago, IL). The level of signif-
icance was set at p < .05.
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Results
Sample Characteristics
One hundred forty people with T2D took part in the 
study. Participants were 63.67 (SD = 7.02) years old on 
average, mostly of White ethnicity, and with relatively 
low household incomes. The majority of participants 
held a degree/university undergraduate level certificate 
or above. The average BMI was within the obese range 
(BMI  >  30  kg/m2) and the mean HbA1c was 7.32 % 
(SD  =  1.49). The majority of participants were taking 
oral antidiabetic medication, anti-hypertensive medica-
tion, and cholesterol-lowering drugs. Out of 140 par-
ticipants, 34 participants had missing data for at least 
one IL-6 measurement, 33 for at least one IL-1Ra meas-
urement, and 34 participants for at least one MCP-1 
measurement, owing to issues in blood sampling. More 
specifically, as the majority of participants were obese, 
maintaining a functioning cannula for the duration of 
the session presented technical challenges; the cannula 
failed part-way through the laboratory procedure for 
some participants. We had a protocol to not reattempt 
blood draw in these participants so as to minimize dis-
tress. Sensitivity analysis showed that participants of 
higher BMI were more likely to have missing data on 
inflammatory markers (t = −3.162, p = .003, d = 0.654), 
but there were no other differences between those with 
and without missing data.
Sample characteristics and associations with happi-
ness are presented in Table 1. The mean happiness score 
was 2.61 (SD  =  0.87) and was not related to age, sex, 
BMI, smoking status, medication use, HbA1c, or physi-
cal activity. Moreover, no significant differences in hap-
piness were observed for household income, educational 
level, or ethnicity groups. There were no significant cor-
relations between happiness and subjective stress rat-
ings at baseline or the three time points following stress. 
The association between happiness and marital status 
approached significance (F = 2.987, p = .054, η2p = 0.048). 
We also found a significant negative correlation between 
happiness and daily mean sadness (r = 0.337, p < .001).
We found significant negative correlations between 
baseline IL-6 and IL-6 responses at the three time points 
post-task (immediately post-task response: r = −0.210, 
p = .018, 45 min response: r = −0.266, p = .004, 75 min 
response: r  =  −0.416, p  <  .001), and between baseline 
MCP-1 and 75 min response (r = −0.342, p < .001).
Trial Validity: Subjective Stress and Inflammatory 
Levels Across Laboratory Session
We found a significant main effect of stress trial for 
the subjective stress ratings (F  =  334.786, p  <  .001, 
η2p = 0.717). There were marked increases in subjective 
stress ratings immediately after the tasks compared with 
baseline levels (p <  .001), with values returning to pre-
task levels during recovery period.
Significant main effects of trial were also found for 
IL-6 (F = 5.961, p = .001, η2p = 0.054). IL-6 increased 
over time, being significantly higher at 75 min post-task 
compared with baseline (p = .021), and immediately post-
task values (p < .001). The average increase from baseline 
levels to 75  min was 0.23 pg/ml. No significant effects 
of stress trial were observed for IL-1Ra (F  =  0.204, 
p = .876, η2p = 0.002). By contrast, MCP-1 showed a pro-
gressive decline across the session (F = 8.262, p < .001, 
η2p = 0.072), so that values at 75 min were significantly 
lower than baseline (p < .001) and immediately post-task 
(p = .003). The average decrease from baseline to 75 min 
was 7.87 pg/ml. Table 2 presents the subjective stress and 
inflammatory levels of the participants across the labo-
ratory session.
Happiness and Inflammatory Markers
IL-6
Higher happiness predicted significantly lower plasma 
IL-6 concentrations for all four time points: base-
line (B  =  −0.110, p  =  .043), immediately post-task 
(B = −0.099, p =  .045), 45 min post-task (B = −0.120, 
p = .028), and 75 min post-task (B = −0.114, p = .033). 
These effects were independent of age, sex, BMI, smok-
ing, household income, marital status, oral antidiabetic 
medication, insulin/other injectable diabetic medication, 
and time of testing. Regression models were repeated 
with the inclusion of daily mean sadness and significant 
results were maintained (baseline: B = −0.145, p = .015; 
immediately post-task: B  =  −0.149, p  =  .006; 45  min 
post-task: B = −0.143, p = .018; and 75 min post-task: 
B = −0.153, p =  .007, see Table 3). Happiness was not 
significantly related to IL-6 change scores (B values 
between −0.022 and −0.011, and p ≥ .410) indicating no 
associations with IL-6 stress responses.
IL-1Ra
We did not find any associations between happiness and 
IL-1Ra before or after stress tasks (B values between 
−0.043 and −0.025, and p  ≥  .352). There were also no 
significant associations between happiness and IL-1Ra 
stress responses (B values between −0.027 and −0.013, 
and p ≥ .072).
MCP-1
Participants with higher happiness score had sig-
nificantly lower baseline MCP-1 concentrations 
(B = −7.815, p = .041) independently of age, sex, BMI, 
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Table 2.  Subjective and inflammatory responses to stress
n Baseline Immediately post-task 45 min post-task 75 min post-task
Subjective stress 133 1.50a (0.90) 4.50b (1.52) 1.53a (0.96) 1.43a (0.93)
IL-6 (pg/ml) 106 2.08a (1.17) 2.07a (1.11) 2.18 (1.23) 2.31b (1.28)
MCP-1(pg/ml) 107 116.90a (33.84) 115.72a (38.07) 113.08 (36.68) 109.04b (32.15)
IL-1Ra (pg/ml) 106 815.70 (416.84) 815.77 (403.44) 823.28 (415.39) 819.94 (420.77)
Values are presented as means and SD. IL-1Ra interleukin-1 receptor antagonist; IL-6 interleukin-6; MCP-1 monocyte chemoattractant 
protein-1. Values in rows with different superscripts (a, b) are significantly different from one another (p < .05).
Table 1. Sample characteristics and associations with daily mean happiness (N = 122)
Characteristic n (%) or M ± SD
Associations with happinessa:  
p value, effect size
Sex, n (%) females 44 (36.1) p = .868, d = .034
Age, M (SD) years 63.67 (7.02) p = .634, r = .044
Smoking, n (%) smokers 18 (14.8) p = .315, d = .263
BMI, M (SD) kg/m2 30.54 (5.59) p = .463, r = .067
Marital status, n (%) p = .054, η2p = .048
 Married 62 (50.8)
 Single 26 (21.3)
 Divorced, separated, or widowed 34 (27.9)










Educational levelb, n (%) p = .345, η2p = .042
 No qualifications (elementary school diploma) 10 (8.3)
 Up to O levels (middle or junior high school diploma) 21 (17.5)
 A-levels/ONC (high school or senior high school diploma) 12 (10)
 Degree (university undergraduate certificate) or above 77 (64.2)
Insulin/other injectable diabetic medication, n (%) yes 15 (12.3) p = .661, d = .120
Oral antidiabetic medication, n (%) yes 98 (80.3) p = .077, d = .430
Anti-hypertensive medication, n (%) yes 85 (69.7) p = .077, d = .330
Beta-blocker, n (%) yes 11 (9.0) p = .620, d = .193
Cholesterol-lowering drugs, n (%) yes 94 (77.0) p = .554, d = .117
Aspirin, n (%) yes 44 (36.1) p = .557, d = .115
Time of testing, n (%) am 55 (45.1) p = .576, d = .103
HbA1cc, M (SD) % 7.32 (1.49) p = .173, r = −.126
Moderate/vigorous physical activityd, M (SD) hours/week 4.61 (8.56) p = .162, r = .133
Daily happiness, M (SD) 2.61 (0.87) –
Daily sadnesse, M (SD) 0.74 (0.73) p ≤ .001, r = −.337
BMI body mass index; HbA1c glycated haemoglobin; ONC ordinary national certificate.
aAssociations between happiness and sample characteristics were tested using Pearson’s r correlations for continuous variables, and t-tests 
and one-way between-subjects analysis of variance (ANOVA) for categorical variables; bn = 120;cn = 118; dn = 112; en = 120.
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Table 3.  Multiple regressions on daily happiness predicting baseline and post-task IL-6 (ln) after adjusting for covariates
B SE ß 95% CI p-value
Baseline IL-6 (N = 111)
Happiness −0.145 0.058 −0.226 −0.261 to −0.029 .015
Age 0.004 0.007 0.053 −0.010 to 0.019 .571
Sex −0.192 0.099 −0.165 −0.389 to 0.004 .055
BMI 0.044 0.010 0.440 0.025 to 0.063 <.001
Smoking 0.271 0.138 0.175 −0.003 to 0.545 .053
Household income −0.064 0.046 −0.135 −0.154 to 0.027 .166
Marital status 0.024 0.062 0.037 −0.098 to 0.146 .698
Oral antidiabetic 
medication
0.048 0.117 0.035 −0.184 to 0.279 .683
Insulin/other injectable 
diabetic medication
−0.035 0.150 −0.020 −0.333 to 0.262 .813
Time of testing 0.144 0.096 0.128 −0.047 to 0.335 .138
Sadness −0.103 0.069 −0.138 −0.239 to 0.034 .140
Immediately post-task (N = 108)
Happiness −0.149 0.053 −0.241 −0.254 to −0.043 .006
Age 0.008 0.007 0.110 −0.005 to 0.021 .213
Sex −0.094 0.089 −0.084 −0.272 to 0.083 .296
BMI 0.052 0.009 0.534 0.035 to 0.069 <.001
Smoking 0.278 0.128 0.183 0.024 to 0.531 .032
Household income −0.074 0.042 −0.160 −0.157 to 0.010 .084
Marital status −0.041 0.056 -0.065 −0.153 to 0.070 .465
Oral antidiabetic 
medication
0.086 0.105 0.066 −0.122 to 0.294 .412
Insulin/other injectable 
diabetic medication
−0.012 0.133 −0.007 −0.277 to 0.253 .927
Time of testing 0.256 0.087 0.236 0.083 to 0.429 .004
Sadness −0.150 0.065 −0.201 −0.279 to −0.020 .025
45 min post-task (N = 99)
Happiness −0.143 0.060 −0.230 −0.261 to −0.025 .018
Age 0.008 0.008 0.099 −0.007 to 0.023 .318
Sex −0.026 0.099 −0.023 0.222 to 0.171 .795
BMI 0.047 0.010 0.459 0.027 to 0.066 <.001
Smoking 0.208 0.137 0.141 −0.065 to 0.481 .134
Household income −0.097 0.046 −0.212 −0.189 to −0.006 .038
Marital status 0.047 0.062 −0.076 −0.170 to 0.075 .446
Oral antidiabetic 
medication
0.059 0.113 0.047 −0.165 to 0.283 .601
Insulin/other injectable 
diabetic medication
−0.008 0.154 −0.005 −0.314 to 0.298 .957
Time of testing 0.245 0.097 0.226 0.052 to 0.438 .014
Sadness −0.073 0.075 −0.098 −0.223 to 0.077 .333
75 min post-task (N = 95)
Happiness −0.153 0.056 −0.263 −0.264 to −0.042 .007
Age 0.005 0.007 0.068 −0.009 to 0.018 .494
Sex −0.021 0.091 −0.020 −0.202 to 0.160 .819
BMI 0.048 0.009 0.480 0.029 to 0.066 <.001
Smoking 0.235 0.124 0.178 −0.012 to 0.481 .061
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smoking, household income, marital status, oral antidi-
abetic medication, insulin/other injectable diabetic med-
ication, and time of testing (Table 4). The associations 
between happiness and MCP-1 levels post-task were not 
significant (immediately post-task: B = −8.172, p = .062; 
45 min post-task: B = 5.819, p = .172; and 75 min post-
task: B = 5.853, p =  .141). After the inclusion of daily 
mean sadness, results for baseline MCP-1 were rendered 
nonsignificant (B  =  −6.311, p  =  .131). There were no 
significant associations between happiness and MCP-1 
stress responses (B values between 1.047 and 0.170, and 
p ≥ .606).
Discussion
We investigated the relationship between daily happi-
ness and three inflammatory markers at resting and in 
response to mental stress tasks in people with T2D. The 
two tasks elicited significant increases in subjective stress 
and in IL-6. IL-6 was not significantly different from 
baseline until 75  min post-task, in agreement with the 
evidence of a relatively delayed IL-6 stress responsivity 
[18]. Interestingly, the stress of the tasks did not translate 
into significant increases in IL-1Ra or MCP-1 in people 
with diabetes, as observed in healthy samples [9, 18, 19]. 
One possibility is that the type of tasks or the timing of 
post-stress sampling played a role. In a previous study, 
IL-1Ra reached a peak at 90 min following social stress 
test [54]. In addition, in another study IL-1Ra showed a 
significant increase only at 120 min post-task [55]. IL-6 
is one of the most frequent measured markers in labora-
tory studies as it is most consistently responsive to acute 
stress [18], and our findings add to the value of measur-
ing IL-6 stress responsivity in people with T2D.
We hypothesized that participants with greater daily 
happiness would have lower IL-6, IL-1Ra, and MCP-1 
concentrations at baseline and after stress, and smaller 
inflammatory stress responses, independently of covar-
iates including daily sadness. Although we did not find 
any differential response to stress in people varying in 
happiness over the day, daily happiness predicted signif-
icantly lower IL-6 at baseline and all later time points, 
Table 4 Multiple regression on daily happiness predicting baseline MCP-1 after adjusting for covariates (N = 117)
B SE ß 95% CI p-value
Happiness −7.815 3.782 −0.193 −15.314 to −0.316 .041
Age 0.890 0.486 0.180 −0.073 to 1.853 .070
Sex −2.955 6.845 −0.040 −16.526 to 10.616 .667
BMI 0.894 0.654 0.141 −0.403 to 2.191 .175
Smoking 8.190 9.487 0.084 −10.619 to 26.998 .390
Household income −2.646 3.126 −0.088 −8.843 to 3.551 .399
Marital status 1.964 4.225 0.048 −6.412 to 10.340 .643
Oral antidiabetic 
medication
−4.719 8.121 −0.055 −20.819 to −11.381 .562
Insulin/other injectable 
medication
4.241 9.865 0.040 −15.318 to 23.800 .688
Time of testing 3.579 6.578 0.51 −9.463 to −16.621 .587
B unstandardized beta coefficient; CI confidence interval; MCP-1 monocyte chemoattractant protein-1; ß standardized beta coefficient; 
BMI body mass index; SE standard error. Bold values indicate statistically significant.
B SE ß 95% CI p-value
Household income −0.067 0.043 −0.162 −0.153 to 0.018 .120
Marital status −0.059 0.057 −0.103 −0.172 to 0.054 .305
Oral antidiabetic 
medication
0.108 0.101 0.095 −0.094 to 0.309 .291
Insulin/other injectable 
diabetic medication
0.018 0.143 0.011 −0.265 to 0.302 .899
Time of testing 0.245 0.088 0.247 0.070 to 0.421 .007
Sadness −0.170 0.069 −0.248 −0.306 to 0.033 .016
B unstandardized beta coefficient; CI confidence interval; IL-6 interleukin-6; ln log n; ß standardized beta coefficient; BMI body mass 
index; SE standard error. Bold values indicate statistically significant.
Table 3. Continued
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and lower baseline MCP-1. These effects were independ-
ent of age, sex, BMI, smoking, household income, mar-
ital status, oral antidiabetic medication, insulin/other 
injectable diabetic medication, and time of testing. The 
association between happiness and IL-6 remained after 
further controlling for daily sadness.
Previous studies of healthy individuals and people 
with heart failure recorded lower IL-6 concentrations in 
those reporting greater positive affect, but samples had 
only been analyzed under resting conditions [30–34]. The 
present results indicate that similar patterns exist in peo-
ple with T2D. However, we did not observe differential 
inflammatory responses to stress in relation to happi-
ness. This contrasts with our previous findings that IL-6 
responses are reduced in more optimistic individuals 
[41]. In our study, IL-6 levels increased in parallel in peo-
ple reporting higher and lower happiness. Consequently, 
absolute levels of IL-6 were greater in less happy people 
both before and after stress testing. The difference from 
previous studies involving healthy individuals may be 
related to the dysregulation of inflammatory, cardiovas-
cular, metabolic, and neuroendocrine systems observed 
in T2D. Specifically, we recently found that people with 
T2D have increased basal IL-6 levels and show smaller 
IL-6 stress responses, compared with a healthy con-
trol group [22]. In the same study, people with diabetes 
showed smaller responses in systolic blood pressure, cor-
tisol, and cholesterol, along with delayed recovery in sys-
tolic and diastolic blood pressure, cholesterol, and heart 
rate [22]. These physiological disturbances across multi-
ple systems are indicative of heightened allostatic load in 
people with T2D, and might have accounted for the null 
findings on happiness and IL-6 stress responses in the 
current study.
Greater happiness was associated with lower baseline 
MCP-1. These findings add to the evidence that MCP-1 
is sensitive to psychosocial factors [19, 37–39]. Contrary 
to our hypothesis, we did not find significant association 
between happiness and baseline IL-1Ra. Nevertheless, 
happiness represents only one dimension of subjec-
tive well-being, and a previous study has shown that in 
patients with heart failure, different positive affect meas-
ures are associated with different markers of inflam-
mation [34]. Future research is needed to investigate 
associations between distinct positive constructs and 
different inflammatory markers in people with T2D, as 
well as their prospective association with objective health 
outcomes. We did not observe significant relationships 
between happiness and MCP-1 or IL-1Ra post-stress, 
or stress responses. These markers did not increase in 
response to the tasks, contrary to IL-6. Future studies 
need to replicate findings for IL-1Ra and MCP-1 in peo-
ple with T2D.
Happiness was associated with lower IL-6 concen-
trations independently of negative mood, in line with 
previous studies [30, 34]. These findings suggest that the 
presence of happiness per se rather than the absence of 
sadness is associated with lower IL-6. Happiness may 
reflect a unique component of psychobiological pro-
cesses taking place in people with T2D, and may be a 
better predictor of basal inflammatory function than 
neutral or sad affect.
The pathways linking happiness with lower circu-
lating inflammatory factors are unclear. Nevertheless, 
ample evidence supports a bidirectional relationship 
between mood and inflammatory markers. For example, 
in both animal and human studies, the administration 
of pro-inflammatory cytokines increased the incidence 
of depressive symptoms [56]. Pre-clinical evidence shows 
that cytokines, including IL-6, act centrally to induce 
mood symptoms [56]. Therefore, lower basal inflam-
matory factors may have contributed to greater happi-
ness. On the other hand, a number of laboratory studies 
demonstrated that psychological stress can induce an 
inflammatory response [9, 18]. Happier individuals may 
use more adaptive coping mechanisms when faced with 
daily stressors, resulting in a better basal activity of the 
stress-related systems, including the immune system.
Clinical Implications
The lower IL-6 recorded in happier individuals with 
diabetes might contribute to reduced progression of 
diabetes in processes such as insulin resistance and 
dyslipidemia. High IL-6 concentrations inhibit AMP-
activated protein kinase, an enzyme related in fatty acid 
oxidation, down-regulating the expression of genes 
involved in insulin-stimulated glucose transport and 
lipid uptake in adipose tissue [21]. Heightened IL-6 has 
been associated with new onset T2D in prospective [20] 
and cross-sectional studies [21], and pro-inflammatory 
states in people with the condition have been associated 
with macrovascular complications [28, 57].
Happiness might also contribute to a lower risk 
of  cardiovascular disease (CVD) in people with T2D 
through reduced inflammatory factors. Elevated IL-6 
concentrations are predictive of  future CVD [23, 
58] and poorer outcomes in people with established 
CVD [59]. In the ADVANCE trial of  3,865 people 
with T2D and established CVD risk factors, IL-6 was 
associated with future fatal and non-fatal cardiovas-
cular events, after adjusting for other inflammatory 
markers including fibrinogen and C-reactive protein 
(CRP [28]). Moreover, two large-scale genetic studies 
provided evidence for a causal relationship between 
the IL-6 pathway and CHD. More precisely, it was 
found that the Asp358Ala variant in the IL-6 receptor 
gene, which attenuates IL-6 signaling on hepatocytes, 
monocytes, and macrophages, was associated with 
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reduced production of  CRP and fibrinogen, and sub-
sequently, a reduced risk of  CHD [60, 61]. Moreover, 
human and animal investigations provide evidence 
that MCP-1 is involved in the development of  CVD 
[62], since heightened MCP-1 has been associated 
with subclinical atherosclerosis and newly diagnosed 
CHD [25]. Elevated MCP-1 levels may contribute to 
the pathogenesis of  vascular diseases by enhancing 
recruitment of  leukocytes to sites of  inflammation 
to the vessel wall [63]. Another potential molecular 
mechanism is that MCP-1-induced protein (MCPIP), 
a novel zinc-finger protein, promotes oxidative and 
nitrosative stress that causes endoplasmic reticulum 
stress which leads to autophagy and cardiac cell death 
involved in heart failure [62].
Given that inflammatory markers are adversely 
related to diabetes pathology, positive psychology 
interventions to improve feelings of  happiness are 
likely to be beneficial for this population, reflecting 
physiological outcomes important to health. A small, 
randomized trial targeting positive emotions in adults 
with T2D demonstrated a significant effect in reduc-
ing depressive symptoms in the intervention group 
[64]. Also, previous studies in patients with other 
chronic conditions showed that positive psychology 
interventions can lead to improvements in health 
behaviors and medication adherence [6]. This offers 
the possibility that these interventions in patients with 
T2D could also have an effect on behavioral adher-
ence. Interestingly though, happiness was not related 
to diabetes control in this study, measured by HbA1c. 
Participants with higher HbA1c could be expected to 
be less happy, but people reported being happy inde-
pendently of  their glycemic control. Further studies 
are needed to confirm the efficacy of  positive psy-
chology interventions in people with diabetes and the 
mediating pathways.
Study Strengths and Limitations
We deliberately recorded mood ratings repeatedly over 
several days so as to obtain an estimate of average hap-
piness that was not biased by transient moods on a sin-
gle occasion. We examined three inflammatory markers 
and their patterns of stress responsivity using a standard 
stress protocol. Although the study includes a relatively 
large sample of adults with diabetes, we were only able 
to collect full biological data on about three quarters of 
participants due to difficulties in blood sampling. The 
present study is also limited by the fact that laboratory 
responses were only tested on one occasion, and causal 
relationships between greater happiness in daily life and 
lower inflammatory markers cannot be drawn. Future 
studies need to shed light on the prospective association 
between happiness, inflammatory markers, and objec-
tive health outcomes in people with T2D. We included a 
long post-task blood sampling period. Nevertheless, an 
extended sampling phase could have provided additional 
information. Participants of this study were middle-aged 
men and women with T2D and without a history of 
CHD. They were recruited from the London area and 
most of them were of White European ethnicity, thus 
we do not know how far the results generalize to other 
cohorts.
Conclusions
Lower baseline and post-stress IL-6 and lower base-
line MCP-1 concentrations were observed in happier 
participants with T2D, independent of  covariates. 
Significant associations for IL-6 were maintained 
after controlling for daily sadness. These findings sug-
gest that greater happiness in daily life is related to 
decreased circulating inflammatory factors in adults 
with T2D, and that the effect of  happiness is above and 
beyond the absence of  sadness. Happiness in people 
with diabetes may contribute to better physical health 
through reduced inflammatory markers, but longi-
tudinal studies are needed to confirm this protective 
pathway.
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